Gregory Weaver

From 1999-2002 was CFO of Ilex Oncology Inc., a cancer drug development company. From 1996-1998 served as CFO of medical device manufacturer Prism Technologies. A certified public accountant, he began his career at Arthur Andersen.

  • 2005 Second Quarter

Added to: Celsion Corp. - Columbia, MD

Celsion is a biotechnology company engaged in the treatment of breast cancer. Revenues are $4 million.